Century Therapeutics logo

Century Therapeutics

IPSC | NASDAQ
Chart Builder DCF Calculator
$1.64
-$0.01 (-0.61%)
At close: Nov 16, 2026, 4:00 PM ET
$1.64
$0.00 (-0.18%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.61%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
45.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #383/1021 (Top 38%)

Key Statistics

Market Data

Market Cap $338.56M
1D Range
1.57 1.71
52W Range
0.48 2.94

Valuation (TTM)

PE -2.19
PB 1.61
EV/EBITDA -2.96

Valuation (NTM)

Forward PE N/A
Forward PEG -0.01
Price Target $3.00
Loading financial charts...

Profile

Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's for...

Sector Healthcare
Industry Biotechnology
Employees 78
IPO Date Jun 18, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$3.00
Upside
+82.93%
Buy (2)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.